While kinase inhibitors demonstrate great promise for disease treatment and management, target selectivity is a common challenge in drug development. KINOMEscan™ (a division of Ambit Biosciences) addresses this problem with a portfolio of over 400 robust kinase assays including the largest collection of lipid, TK, and mutant kinase assays available. KINOMEscan employs a proprietary high-throughput, competition binding assay platform to screen one to thousands of compounds quickly and economically and provides researchers with reproducible high quality data to support discovery programs. KINOMEscan’s flexible kinase panel is suitable for detecting many types of allosteric modulators and has been validated through major pharmaceutical partnerships.
Kinase Selectivity Profiling Services
The new 405™ Touch Microplate Washer incorporates a state-of-the-art, high resolution... watch video
We use the S-96 Satellite Gradient Thermal Cycler from Quanta Biotech. This... read more
Stay updated on the latest technologies and news with Biocompare's newsletters (See samples here)